This week, 12 Health Care Equipment & Supplies stocks are improving their overall rating on Portfolio Grader. Each of these rates an “A” (“strong buy”) or “B” overall (“buy”).
This is a strong week for Zimmer Biomet Holdings, Inc. (ZBH). The company’s rating climbs to A from the previous week’s B. The company also gets A’s in sales growth and earnings momentum. For more information, get Portfolio Grader’s complete analysis of ZBH stock.
IDEXX Laboratories, Inc. (IDXX) is seeing ratings go up from a B last week to a A this week. IDEXX Laboratories, Inc. provides diagnostic, detection, and information systems for veterinary, food, and water testing applications. The company also gets A’s in earnings revisions. For more information, get Portfolio Grader’s complete analysis of IDXX stock.
Analogic Corporation’s (ALOG) ratings are looking better this week, moving up to a B from last week’s C. Analogic Corporation is a technology company that designs and manufactures medical imaging and security systems and subsystems that are used primarily in the healthcare and airport security markets. For more information, get Portfolio Grader’s complete analysis of ALOG stock.
Integra LifeSciences Holdings Corporation (IART) improves from a B to a A rating this week. Integra LifeSciences Holdings Corporation develops, manufactures, and markets medical devices, implants, and biomaterials. The company also gets A’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of IART stock.
This week, Utah Medical Products, Inc. (UTMD) pushes up from a B to a A rating. Utah Medical Products, Inc. produces and markets medical devices for the healthcare industry. The company also gets A’s in return on equity. For more information, get Portfolio Grader’s complete analysis of UTMD stock.
Insulet Corporation (PODD) shows solid improvement this week. The company’s rating rises from a C to a B. Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes. The company also gets A’s in sales growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of PODD stock.
This week, Exactech, Inc.’s (EXAC) ratings are up from a B last week to a A. Exactech, Inc. develops, manufactures, markets, and sells orthopedic implant devices and related surgical instrumentation. For more information, get Portfolio Grader’s complete analysis of EXAC stock.
MGC Diagnostics Corporation (MGCD) gets a higher grade this week, advancing from a B last week to a A. The company also gets A’s in free cash flow. For more information, get Portfolio Grader’s complete analysis of MGCD stock.
The rating of Lantheus Holdings Inc (LNTH) moves up this week, rising from a C to a B. The company also gets A’s in earnings growth, earnings revisions, earnings surprise, and earnings momentum. For more information, get Portfolio Grader’s complete analysis of LNTH stock.
CRH Medical Corporation (CRHM) earns a B this week, jumping up from last week’s grade of C. The company also gets A’s in sales growth, operating margin growth, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of CRHM stock.
Check-Cap Ltd. (CHEK) boosts its rating from a D to a B this week. The company also gets A’s in earnings revisions and earnings momentum. For more information, get Portfolio Grader’s complete analysis of CHEK stock.
Bovie Medical Corporation (BVX) is seeing ratings go up from a D last week to a B this week. Bovie Medical Corporation develops, manufactures, and markets medical products and devices with an emphasis on electrosurgical generators and electrosurgical disposables in the United States, Canada, and internationally. The company also gets A’s in sales growth, earnings revisions, and earnings surprise. For more information, get Portfolio Grader’s complete analysis of BVX stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
